Tags

Type your tag names separated by a space and hit enter

Treatment of morbid obesity with intragastric balloon in association with diet.

Abstract

BACKGROUND

The BioEnterics Intragastric Balloon (BIB, BioEnterics, Santa Barbara, CA) in association with restricted diet has been used for the treatment of obesity and morbid obesity.

METHODS

Since March 1998, 322 BIB were placed in 281 obese and morbidly obese patients; 73 patients were male and 208 female; mean age was 41.6 years (21-70); mean weight was 117.4 kg (67-229); mean BMI was 41.8 kg/m2 (29-81); % excess weight was 62% (10-216). The balloon was inserted and removed endoscopically under general anesthesia. Patients were given a balanced diet of 1000 kcal/day. Also, for 18 months we compared 42 obese patients treated only with 1000 kcal/day diet (group A) with 31 obese patients subjected to BIB for 4 months + 1000 kcal/day diet (group B).

RESULTS

After 4 months of balloon treatment, the mean weight loss was 13.9 kg and the mean reduction in BMI was 4.8. Weight loss was greater in male patients. Weight loss was accompanied by an improvement of the diseases associated with obesity, in particular diabetes. In the diet vs BIB + diet study, BIB with diet produced a greater weight loss in a shorter time than diet alone.

CONCLUSION

The best indications for BIB were: morbidly obese opatients (BMI > 40) and super-obese patients (BMI > 50) in preparation for bariatric operations; obese patients with BMI 35-40 with co-morbilities in preparation for bariatric surgery; obese patients with BMI 30-35 with a chronic disease otherwise unresolved; patients with BMI < 30 only in a multidisciplinary approach.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Cattedra di Chirurgia Generale dell'Università degli Studi di Milano, Unità Operativa di Chirurgia Generale, Istituto Clinico Sant'Ambrogio di Milano, Italy. sbdoldi@tiscali.it

    , , ,

    Source

    Obesity surgery 12:4 2002 Aug pg 583-7

    MeSH

    Adult
    Aged
    Body Mass Index
    Combined Modality Therapy
    Diet, Reducing
    Female
    Follow-Up Studies
    Gastric Balloon
    Humans
    Male
    Middle Aged
    Obesity, Morbid
    Postoperative Complications
    Treatment Outcome
    Weight Loss

    Pub Type(s)

    Comparative Study
    Journal Article

    Language

    eng

    PubMed ID

    12194556

    Citation

    Doldi, S B., et al. "Treatment of Morbid Obesity With Intragastric Balloon in Association With Diet." Obesity Surgery, vol. 12, no. 4, 2002, pp. 583-7.
    Doldi SB, Micheletto G, Perrini MN, et al. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg. 2002;12(4):583-7.
    Doldi, S. B., Micheletto, G., Perrini, M. N., Librenti, M. C., & Rella, S. (2002). Treatment of morbid obesity with intragastric balloon in association with diet. Obesity Surgery, 12(4), pp. 583-7.
    Doldi SB, et al. Treatment of Morbid Obesity With Intragastric Balloon in Association With Diet. Obes Surg. 2002;12(4):583-7. PubMed PMID: 12194556.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Treatment of morbid obesity with intragastric balloon in association with diet. AU - Doldi,S B, AU - Micheletto,G, AU - Perrini,M N, AU - Librenti,M C, AU - Rella,S, PY - 2002/8/27/pubmed PY - 2003/1/15/medline PY - 2002/8/27/entrez SP - 583 EP - 7 JF - Obesity surgery JO - Obes Surg VL - 12 IS - 4 N2 - BACKGROUND: The BioEnterics Intragastric Balloon (BIB, BioEnterics, Santa Barbara, CA) in association with restricted diet has been used for the treatment of obesity and morbid obesity. METHODS: Since March 1998, 322 BIB were placed in 281 obese and morbidly obese patients; 73 patients were male and 208 female; mean age was 41.6 years (21-70); mean weight was 117.4 kg (67-229); mean BMI was 41.8 kg/m2 (29-81); % excess weight was 62% (10-216). The balloon was inserted and removed endoscopically under general anesthesia. Patients were given a balanced diet of 1000 kcal/day. Also, for 18 months we compared 42 obese patients treated only with 1000 kcal/day diet (group A) with 31 obese patients subjected to BIB for 4 months + 1000 kcal/day diet (group B). RESULTS: After 4 months of balloon treatment, the mean weight loss was 13.9 kg and the mean reduction in BMI was 4.8. Weight loss was greater in male patients. Weight loss was accompanied by an improvement of the diseases associated with obesity, in particular diabetes. In the diet vs BIB + diet study, BIB with diet produced a greater weight loss in a shorter time than diet alone. CONCLUSION: The best indications for BIB were: morbidly obese opatients (BMI > 40) and super-obese patients (BMI > 50) in preparation for bariatric operations; obese patients with BMI 35-40 with co-morbilities in preparation for bariatric surgery; obese patients with BMI 30-35 with a chronic disease otherwise unresolved; patients with BMI < 30 only in a multidisciplinary approach. SN - 0960-8923 UR - https://www.unboundmedicine.com/medline/citation/12194556/Treatment_of_morbid_obesity_with_intragastric_balloon_in_association_with_diet_ L2 - https://dx.doi.org/10.1381/096089202762252398 DB - PRIME DP - Unbound Medicine ER -